Protective effect of chronic NSAID use on cognitive decline in older persons

Renzo Rozzini, Luigi Ferrucci, Kathy Losonczy, Richard J. Havlik, Jack M. Guralnik

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: To verify whether chronic use of nonsteroidal anti- inflammatory drugs (NSAIDs) has a protective effect against cognitive decline in older persons. DESIGN: Prospective study with a 3-year observation period. SETTING: Three communities of the Established Populations for Epidemiologic Studies of the Elderly (EPESE). SUBJECTS: A population-based sample of 7671 subjects who received an in-person interview at the sixth annual follow-up. Persons with documented NSAID use at the time of the interview and 3 years before were considered chronic users (21%), while all other persons were considered as nonusers. MAIN OUTCOME MEASURE: Change over time in cognitive function assessed as the number of correct answers to a 9-item version of the Short Portable Mental Status Questionnaire (SPMSQ). RESULTS: For every level of SPMSQ score measured at the beginning of the observation period, the mean SPMSQ score after 3 years was higher in chronic NSAID users than in nonusers. Cognitive function at the end of the observation period was significantly higher in chronic NSAID users than in controls, adjusting for initial SPMSQ score and potential confounders. Older age, female gender, education, and history of cerebrovascular disease were also independent predictors of lower SPMSQ score. In the multivariate analysis, the magnitude of the protective effect estimated for NSAID use was comparable to a difference in age of 3.5 years. The percentage of persons who started above a specific SPMSQ score cut-point and deteriorated below that cut-point over a 3-year period was significantly lower in chronic NSAID users than in nonusers (30.2% vs 34.3%, P = .03, for decline below SPMSQ score of 8 and 12.3% vs 14.4% for decline below SPMSQ score of 6, P = .04). After controlling for potential confounders, the relative risk of cognitive declining in chronic NSAID users compared with nonusers was 0.82 (95% Confidence Interval: 0.69-0.98) for a decline below a score of 8, and 0.80 (95% CI: 0.66-0.98) for a decline below a score of 6. CONCLUSIONS: These results support the association between NSAID use and reduction in cognitive decline in older persons. Ultimately, randomized controlled trials must be done to prove a beneficial effect definitively.

Original languageEnglish (US)
Pages (from-to)1025-1029
Number of pages5
JournalJournal of the American Geriatrics Society
Volume44
Issue number9
StatePublished - Sep 1996
Externally publishedYes

Fingerprint

Anti-Inflammatory Agents
Drug Users
Pharmaceutical Preparations
Observation
Cognition
Interviews
Cerebrovascular Disorders
Cognitive Dysfunction
Surveys and Questionnaires
Population
Epidemiologic Studies
Multivariate Analysis
Randomized Controlled Trials
Prospective Studies
Confidence Intervals
Education

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Rozzini, R., Ferrucci, L., Losonczy, K., Havlik, R. J., & Guralnik, J. M. (1996). Protective effect of chronic NSAID use on cognitive decline in older persons. Journal of the American Geriatrics Society, 44(9), 1025-1029.

Protective effect of chronic NSAID use on cognitive decline in older persons. / Rozzini, Renzo; Ferrucci, Luigi; Losonczy, Kathy; Havlik, Richard J.; Guralnik, Jack M.

In: Journal of the American Geriatrics Society, Vol. 44, No. 9, 09.1996, p. 1025-1029.

Research output: Contribution to journalArticle

Rozzini, R, Ferrucci, L, Losonczy, K, Havlik, RJ & Guralnik, JM 1996, 'Protective effect of chronic NSAID use on cognitive decline in older persons', Journal of the American Geriatrics Society, vol. 44, no. 9, pp. 1025-1029.
Rozzini R, Ferrucci L, Losonczy K, Havlik RJ, Guralnik JM. Protective effect of chronic NSAID use on cognitive decline in older persons. Journal of the American Geriatrics Society. 1996 Sep;44(9):1025-1029.
Rozzini, Renzo ; Ferrucci, Luigi ; Losonczy, Kathy ; Havlik, Richard J. ; Guralnik, Jack M. / Protective effect of chronic NSAID use on cognitive decline in older persons. In: Journal of the American Geriatrics Society. 1996 ; Vol. 44, No. 9. pp. 1025-1029.
@article{17ab4a9fee5e42f4ae1317bcb13dddb6,
title = "Protective effect of chronic NSAID use on cognitive decline in older persons",
abstract = "OBJECTIVE: To verify whether chronic use of nonsteroidal anti- inflammatory drugs (NSAIDs) has a protective effect against cognitive decline in older persons. DESIGN: Prospective study with a 3-year observation period. SETTING: Three communities of the Established Populations for Epidemiologic Studies of the Elderly (EPESE). SUBJECTS: A population-based sample of 7671 subjects who received an in-person interview at the sixth annual follow-up. Persons with documented NSAID use at the time of the interview and 3 years before were considered chronic users (21{\%}), while all other persons were considered as nonusers. MAIN OUTCOME MEASURE: Change over time in cognitive function assessed as the number of correct answers to a 9-item version of the Short Portable Mental Status Questionnaire (SPMSQ). RESULTS: For every level of SPMSQ score measured at the beginning of the observation period, the mean SPMSQ score after 3 years was higher in chronic NSAID users than in nonusers. Cognitive function at the end of the observation period was significantly higher in chronic NSAID users than in controls, adjusting for initial SPMSQ score and potential confounders. Older age, female gender, education, and history of cerebrovascular disease were also independent predictors of lower SPMSQ score. In the multivariate analysis, the magnitude of the protective effect estimated for NSAID use was comparable to a difference in age of 3.5 years. The percentage of persons who started above a specific SPMSQ score cut-point and deteriorated below that cut-point over a 3-year period was significantly lower in chronic NSAID users than in nonusers (30.2{\%} vs 34.3{\%}, P = .03, for decline below SPMSQ score of 8 and 12.3{\%} vs 14.4{\%} for decline below SPMSQ score of 6, P = .04). After controlling for potential confounders, the relative risk of cognitive declining in chronic NSAID users compared with nonusers was 0.82 (95{\%} Confidence Interval: 0.69-0.98) for a decline below a score of 8, and 0.80 (95{\%} CI: 0.66-0.98) for a decline below a score of 6. CONCLUSIONS: These results support the association between NSAID use and reduction in cognitive decline in older persons. Ultimately, randomized controlled trials must be done to prove a beneficial effect definitively.",
author = "Renzo Rozzini and Luigi Ferrucci and Kathy Losonczy and Havlik, {Richard J.} and Guralnik, {Jack M.}",
year = "1996",
month = "9",
language = "English (US)",
volume = "44",
pages = "1025--1029",
journal = "Journal of the American Geriatrics Society",
issn = "0002-8614",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Protective effect of chronic NSAID use on cognitive decline in older persons

AU - Rozzini, Renzo

AU - Ferrucci, Luigi

AU - Losonczy, Kathy

AU - Havlik, Richard J.

AU - Guralnik, Jack M.

PY - 1996/9

Y1 - 1996/9

N2 - OBJECTIVE: To verify whether chronic use of nonsteroidal anti- inflammatory drugs (NSAIDs) has a protective effect against cognitive decline in older persons. DESIGN: Prospective study with a 3-year observation period. SETTING: Three communities of the Established Populations for Epidemiologic Studies of the Elderly (EPESE). SUBJECTS: A population-based sample of 7671 subjects who received an in-person interview at the sixth annual follow-up. Persons with documented NSAID use at the time of the interview and 3 years before were considered chronic users (21%), while all other persons were considered as nonusers. MAIN OUTCOME MEASURE: Change over time in cognitive function assessed as the number of correct answers to a 9-item version of the Short Portable Mental Status Questionnaire (SPMSQ). RESULTS: For every level of SPMSQ score measured at the beginning of the observation period, the mean SPMSQ score after 3 years was higher in chronic NSAID users than in nonusers. Cognitive function at the end of the observation period was significantly higher in chronic NSAID users than in controls, adjusting for initial SPMSQ score and potential confounders. Older age, female gender, education, and history of cerebrovascular disease were also independent predictors of lower SPMSQ score. In the multivariate analysis, the magnitude of the protective effect estimated for NSAID use was comparable to a difference in age of 3.5 years. The percentage of persons who started above a specific SPMSQ score cut-point and deteriorated below that cut-point over a 3-year period was significantly lower in chronic NSAID users than in nonusers (30.2% vs 34.3%, P = .03, for decline below SPMSQ score of 8 and 12.3% vs 14.4% for decline below SPMSQ score of 6, P = .04). After controlling for potential confounders, the relative risk of cognitive declining in chronic NSAID users compared with nonusers was 0.82 (95% Confidence Interval: 0.69-0.98) for a decline below a score of 8, and 0.80 (95% CI: 0.66-0.98) for a decline below a score of 6. CONCLUSIONS: These results support the association between NSAID use and reduction in cognitive decline in older persons. Ultimately, randomized controlled trials must be done to prove a beneficial effect definitively.

AB - OBJECTIVE: To verify whether chronic use of nonsteroidal anti- inflammatory drugs (NSAIDs) has a protective effect against cognitive decline in older persons. DESIGN: Prospective study with a 3-year observation period. SETTING: Three communities of the Established Populations for Epidemiologic Studies of the Elderly (EPESE). SUBJECTS: A population-based sample of 7671 subjects who received an in-person interview at the sixth annual follow-up. Persons with documented NSAID use at the time of the interview and 3 years before were considered chronic users (21%), while all other persons were considered as nonusers. MAIN OUTCOME MEASURE: Change over time in cognitive function assessed as the number of correct answers to a 9-item version of the Short Portable Mental Status Questionnaire (SPMSQ). RESULTS: For every level of SPMSQ score measured at the beginning of the observation period, the mean SPMSQ score after 3 years was higher in chronic NSAID users than in nonusers. Cognitive function at the end of the observation period was significantly higher in chronic NSAID users than in controls, adjusting for initial SPMSQ score and potential confounders. Older age, female gender, education, and history of cerebrovascular disease were also independent predictors of lower SPMSQ score. In the multivariate analysis, the magnitude of the protective effect estimated for NSAID use was comparable to a difference in age of 3.5 years. The percentage of persons who started above a specific SPMSQ score cut-point and deteriorated below that cut-point over a 3-year period was significantly lower in chronic NSAID users than in nonusers (30.2% vs 34.3%, P = .03, for decline below SPMSQ score of 8 and 12.3% vs 14.4% for decline below SPMSQ score of 6, P = .04). After controlling for potential confounders, the relative risk of cognitive declining in chronic NSAID users compared with nonusers was 0.82 (95% Confidence Interval: 0.69-0.98) for a decline below a score of 8, and 0.80 (95% CI: 0.66-0.98) for a decline below a score of 6. CONCLUSIONS: These results support the association between NSAID use and reduction in cognitive decline in older persons. Ultimately, randomized controlled trials must be done to prove a beneficial effect definitively.

UR - http://www.scopus.com/inward/record.url?scp=0029811779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029811779&partnerID=8YFLogxK

M3 - Article

C2 - 8790225

AN - SCOPUS:0029811779

VL - 44

SP - 1025

EP - 1029

JO - Journal of the American Geriatrics Society

JF - Journal of the American Geriatrics Society

SN - 0002-8614

IS - 9

ER -